Newsroom

News

According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that 1.27 million deaths worldwide in 2019 were directly attributable to drug-resistant infections.

18.10.2024

HZI Campus

Schematic representation of metagenome data

News

Microorganisms do not just colonize the body of mammals during infections. Billions of microbes can be found on and in healthy humans and animals at any given time, communicating with each other via chemical signals and thus influencing their health. In two studies, researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and Saarland University Hospital have now conducted a detailed study of the microbiome, i.e. the totality of all microorganisms, in humans and zoo animals. The aim was to identify starting points for strategies for the treatment and diagnosis of diseases. The researchers published their results in two articles in the journal Nature Communications. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

17.10.2024

HIPS

Sébastien Calvignac-Spencer with Julia Demann

News

To prepare us for future pandemics, researchers at the Helmholtz Institute for One Health (HIOH) not only look at the pathogens, but also at how changes in the environment and nature - including those caused by us - influence how pathogens have developed in the past. Prof. Sébastien Calvignac-Spencer heads the research group "Evolution of Pathogens" at HIOH and uses genetic changes to retrospectively analyse what could have caused this change. In the HZI podcast InFact, he explains how this allows valuable conclusions to be drawn about how today's pathogens could develop.

14.10.2024

HIOH

News

The intestinal microbiome is currently the subject of intensive research, as it is of great importance for human health. Intestinal bacteria play an essential role in the defense against dangerous pathogens, which is one of the reasons why the majority of them are among the good guys. On the other hand, some of our lodgers are more prevalent in specific diseases - for whatever reason. This also applies to the widespread but little-researched bacterium Segatella copri. The research group led by Prof Till Strowig at the Helmholtz Centre for Infection Research (HZI) wanted to determine what makes this bacterium tick. How does it adapt to its environment? And what signals does it react to?

08.10.2024

HZI Campus

HIRI

Ankündigung des Helmholtz Health Summits am 8. Oktober in Berlin

News

What opportunities lie ahead for the future of medical research and healthcare systems? Researchers from the Helmholtz Association exchange ideas with decision-makers from science, politics, patient organizations, biotech, and the pharmaceutical industry at the Helmholtz Health Summit. The conference focuses on scientific developments that will have a long-term impact on medicine and healthcare. Topics include digital health, artificial intelligence, personalized therapy, prevention, pandemic resilience, and research transfer.

08.10.2024

HZI Campus

HIOH

Feather of the toxic mountain fathead and a plate culture.

News

Bacteria are a valuable source for the discovery of natural products that can be used for the development of new drugs. A HIPS research team has now identified two new classes of active substances with antimicrobial properties from bacteria that live in symbiosis with a toxic bird. This strategy and the substances discovered offer promising avenues towards the development of new anti-infectives, particularly against antibiotic-resistant pathogens. The researchers published their findings in the journal Nature Communications. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

07.10.2024

HIPS

Back to the first page
...
19
20
21
22
...
149

HZI in the media

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025

Bionity.COM

angewiesen.“

Josef Penninger, Genetiker und wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI),

12.12.2025

Brandaktuell

Quelle:

Pressemitteilung Helmholtz-Zentrum für Infektionsforschung HZI ...

10.12.2025

LaborPraxis

Medikament Tolcapon identifiziert. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Kooperation ...

01.12.2025

Homburg

... wissenschaftlicher Ko-Direktor des Helmholtz Zentrums für Infektionsforschung (HZI). Thomas Pietschmann engagiert sich seit 2023 im ...

28.11.2025

juraforum.de

Dr. Alexander Titz, group leader at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). “Finding new ways to disrupt its

28.11.2025

ARCHYDE

... “, sagte die Leiterin der Epidemiologie am Braunschweiger Helmholtz-Zentrum für Infektionsforschung.

Lange betonte, flächendeckende ...

28.11.2025

Evangelische Zeitung

... ein Zentrum für Quantentechnologie entstehen und das Helmholtz-Institut für Pharmazeutische Forschung ausgebaut werden.

Mehr ...

27.11.2025

Tagesschau

Euro werden investiert in die Erweiterung des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS). Und ...

27.11.2025

ZEIT online

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

The

26.11.2025

Medical Xpress

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.